Edgewise Financing Helps Propel Important New Therapies for Muscular Dystrophy

CureDuchenne Ventures is pleased to support Edgewise Therapeutics with innovative research for Duchenne. The Duchenne community needs multiple shots on goal and CureDuchenne continues to lead the way to impactful treatments.

Read the full press release below.